{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T12:16:13Z","timestamp":1771848973896,"version":"3.50.1"},"reference-count":46,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Psoriasis is a chronic systemic inflammatory disease with established extra-cutaneous manifestations. While the association between uveitis and spondyloarthritis (SpA)-related disorders is well recognized, the incident risk of uveitis among broader psoriasis populations remains inadequately defined due to methodological limitations and inconsistent findings across previous studies. We aimed to estimate the incidence of uveitis in a large, nationwide population-based cohort and identify specific clinical and treatment-related predictors of ocular inflammation. Methods: This retrospective cohort study utilised electronic health records from Clalit Health Services, Israel\u2019s largest health maintenance organization (2002\u20132024). We identified 157,360 patients with dermatologist-confirmed psoriasis and 156,927 age- and sex-matched controls. The primary outcome was incident uveitis, with risk estimated using Cox proportional hazards models. Within the psoriasis cohort, multivariable logistic regression was employed to identify predictors of uveitis, ensuring appropriate temporal sequencing between psoriasis treatment exposure and outcome. Results: Over a median follow-up of 12.6 years, psoriasis was associated with a significantly higher risk of incident uveitis (adjusted Hazard Ratio [aHR] 1.80; 95% CI, 1.50\u20132.15). Stratified analysis revealed a graded risk pattern: mild psoriasis showed no increased risk (aHR 1.01; 95% CI, 0.91\u20131.13), whereas severe disease (aHR 1.59; 95% CI, 1.25\u20132.03) and concomitant SpA (aHR 2.21; 95% CI, 1.87\u20132.61) demonstrated markedly elevated risks. Within the psoriasis cohort, independent predictors included SpA, diabetes mellitus, systemic lupus erythematosus, and sarcoidosis. Exposure to biologics, particularly etanercept (OR 3.37; 95% CI, 2.42\u20134.54), was associated with higher odds of uveitis, potentially reflecting higher disease severity. Conclusions: Incident uveitis risk in psoriasis is primarily driven by the magnitude of systemic inflammatory burden, with the highest risk observed in severe disease and those with concomitant SpA. Clinicians should maintain heightened vigilance for ocular symptoms in these high-risk subgroups to ensure timely intervention.<\/jats:p>","DOI":"10.3390\/diagnostics16040627","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T11:39:10Z","timestamp":1771846750000},"page":"627","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Increased Risk of Incident Uveitis Among Patients with Psoriasis: A Nationwide Population-Based Cohort Study"],"prefix":"10.3390","volume":"16","author":[{"given":"Scott","family":"Ehrenberg","sequence":"first","affiliation":[{"name":"Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Ramat Gan 5262100, Israel"},{"name":"Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv 6927846, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5285-6695","authenticated-orcid":false,"given":"Yoav","family":"Elizur","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Ramat Gan 5262100, Israel"},{"name":"Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv 6927846, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4721-2003","authenticated-orcid":false,"given":"Niv","family":"Ben-Shabat","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Ramat Gan 5262100, Israel"},{"name":"Dina Recanati School of Medicine, Reichman University, Herzliya 4610101, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0075-5895","authenticated-orcid":false,"given":"Paula","family":"David","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Ramat Gan 5262100, Israel"},{"name":"Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv 6927846, Israel"},{"name":"Section of Musculoskeletal Disease, The National Institute for Health and Care Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton, Leeds Teaching Hospital Trust, Leeds LS1 3EX, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3905-3313","authenticated-orcid":false,"given":"Kassem","family":"Sharif","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv 6927846, Israel"},{"name":"Center for Advanced Endoscopy, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02108, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yossef S.","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Abu Hilwe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Ramat Gan 5262100, Israel"},{"name":"Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv 6927846, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon D.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Chief Physician\u2019s Office, Clalit Health Services, Tel-Aviv 6209813, Israel"},{"name":"Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1404-8027","authenticated-orcid":false,"given":"Abdulla","family":"Watad","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Ramat Gan 5262100, Israel"},{"name":"Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv 6927846, Israel"},{"name":"Section of Musculoskeletal Disease, The National Institute for Health and Care Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton, Leeds Teaching Hospital Trust, Leeds LS1 3EX, UK"},{"name":"Rheumatology Unit, Sheba Medical Centre, Tel-Hashomer 5262100, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5406-7716","authenticated-orcid":false,"given":"Howard","family":"Amital","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Ramat Gan 5262100, Israel"},{"name":"Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv 6927846, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0412-1729","authenticated-orcid":false,"given":"Yonatan Shneor","family":"Patt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Ramat Gan 5262100, Israel"},{"name":"Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv 6927846, Israel"},{"name":"Education Authority, Sheba Medical Center, Tel-Hashomer 5262100, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.gastro.2005.06.021","article-title":"The Clustering of Other Chronic Inflammatory Diseases in Inflammatory Bowel Disease: A Population-Based Study","volume":"129","author":"Bernstein","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis","volume":"55","author":"Neimann","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","article-title":"Psoriasis Prevalence in Adults in the United States","volume":"157","author":"Armstrong","year":"2021","journal-title":"JAMA Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1007\/s10792-022-02225-5","article-title":"Psoriasis and uveitis","volume":"42","author":"Uzlu","year":"2022","journal-title":"Int. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(14)62113-9","article-title":"Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: A phase 3 randomised non-inferiority trial","volume":"386","author":"Bachelez","year":"2015","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/bjd.19039","article-title":"British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: A rapid update","volume":"183","author":"Smith","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10067-015-2960-8","article-title":"Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease","volume":"34","author":"Rosenbaum","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/ard.2007.075754","article-title":"Prevalence and characteristics of uveitis in the spondyloarthropathies: A systematic literature review","volume":"67","author":"Zeboulon","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/0301-4738.58468","article-title":"Current approach in diagnosis and management of anterior uveitis","volume":"58","author":"Agrawal","year":"2010","journal-title":"Indian J. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s10067-006-0403-2","article-title":"Association of acute anterior uveitis with disease activity, functional ability and physical mobility in patients with ankylosing spondylitis: A cross-sectional study of Chinese patients in Taiwan","volume":"26","author":"Chen","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/1346-8138.17123","article-title":"Unraveling the connection: Uveitis prevalence and risk factors in psoriasis patients\u2014A population-based study","volume":"51","author":"Patt","year":"2024","journal-title":"J. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10067-023-06834-y","article-title":"The risk factors for uveitis among psoriatic arthritis patients: A population-based cohort study","volume":"43","author":"Hijazi","year":"2024","journal-title":"Clin. Rheumatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1365-4632.2011.05424.x","article-title":"Ocular findings in patients with psoriasis","volume":"52","author":"Kilic","year":"2013","journal-title":"Int. J. Dermatol."},{"key":"ref_14","first-page":"210","article-title":"Psoriasis and intraocular inflammation","volume":"77","author":"Knox","year":"1979","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10238-025-01693-0","article-title":"Bidirectional association between uveitis and psoriasis: A systematic review and meta-analysis","volume":"25","author":"Wu","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ajo.2025.09.020","article-title":"Ocular Comorbidities of Psoriasis: A Systematic Review and Meta-analysis of Observational Studies","volume":"281","author":"Wang","year":"2026","journal-title":"Am. J. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jamadermatol.2015.1986","article-title":"Association of Psoriatic Disease with Uveitis","volume":"151","author":"Egeberg","year":"2015","journal-title":"JAMA Dermatol"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Patt, Y.S., Ben-Shabat, N., Sharif, K., Patt, C., Elizur, Y., Arow, M., Cohen, A.D., Watad, A., McGonagle, D., and Amital, H. (2024). The Association Between Sarcoidosis and Malignancy: A Comprehensive Population-Based Cohort Study. J. Clin. Med., 13.","DOI":"10.3390\/jcm13237045"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1093\/rheumatology\/kead526","article-title":"Increased risk of osteoporosis and femoral neck fractures in patients with familial Mediterranean fever-a large retrospective cohort study","volume":"63","author":"Patt","year":"2024","journal-title":"Rheumatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/ijdvl.IJDVL_1239_15","article-title":"Prevalence of ocular findings in a sample of Egyptian patients with psoriasis","volume":"84","author":"Omar","year":"2018","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/jdv.13813","article-title":"Prevalence and comorbidities in adults with psoriasis compared to atopic eczema","volume":"31","author":"Radtke","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/jamaophthalmol.2017.0569","article-title":"Risk of Uveitis Among People with Psoriasis","volume":"135","author":"Chi","year":"2017","journal-title":"JAMA Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/jdv.19060","article-title":"Risk of uveitis in patients with psoriasis in Korea: A nationwide population-based cohort study","volume":"37","author":"Kim","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ziade, N.R. (2017). HLA B27 antigen in Middle Eastern and Arab countries: Systematic review of the strength of association with axial spondyloarthritis and methodological gaps. BMC Musculoskelet. Disord., 18.","DOI":"10.1186\/s12891-017-1639-5"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/IIO.0000000000000072","article-title":"The Role of Sex in Uveitis and Ocular Inflammation","volume":"55","author":"Yeung","year":"2015","journal-title":"Int. Ophthalmol. Clin."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Giorgiutti, S., Jacquot, R., El Jammal, T., Bert, A., Jamilloux, Y., Kodjikian, L., and S\u00e8ve, P. (2023). Sarcoidosis-Related Uveitis: A Review. J. Clin. Med., 12.","DOI":"10.3390\/jcm12093194"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.sjopt.2016.02.001","article-title":"Ocular findings in systemic lupus erythematosus","volume":"30","author":"Shoughy","year":"2016","journal-title":"Saudi J. Ophthalmol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1080\/09273948.2025.2548333","article-title":"The Association of Diabetes Mellitus with Uveitis: A Real-World Data Analysis","volume":"33","author":"Jindal","year":"2025","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Jiang, Q., Li, Z., Tao, T., Duan, R., Wang, X., and Su, W. (2021). TNF-\u03b1 in Uveitis: From Bench to Clinic. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.740057"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Leclercq, M., Desbois, A.C., Domont, F., Maalouf, G., Touhami, S., Cacoub, P., Bodaghi, B., and Saadoun, D. (2020). Biotherapies in Uveitis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113599"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3109\/02713683.2010.486520","article-title":"Anti-TNF-\u03b1 Treatment: A Possible Promoter in Endogenous Uveitis? Observational Report on Six Patients: Occurrence of Uveitis Following Etanercept Treatment","volume":"35","author":"Kakkassery","year":"2010","journal-title":"Curr. Eye Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.semarthrit.2011.05.005","article-title":"New Onset of Uveitis During Anti-Tumor Necrosis Factor Treatment for Rheumatic Diseases","volume":"41","author":"Wendling","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Egwuagu, C.E., Alhakeem, S.A., and Mbanefo, E.C. (2021). Uveitis: Molecular Pathogenesis and Emerging Therapies. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.623725"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6693542","DOI":"10.1155\/2021\/6693542","article-title":"Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis","volume":"2021","author":"Guo","year":"2021","journal-title":"J. Immunol. Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Chen, Y.H., Lightman, S., and Calder, V.L. (2021). CD4+ T-Cell Plasticity in Non-Infectious Retinal Inflammatory Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179584"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.imlet.2019.03.016","article-title":"The role of ocular dendritic cells in uveitis","volume":"209","author":"Lin","year":"2019","journal-title":"Immunol. Lett."},{"key":"ref_37","first-page":"7692024","article-title":"T Helper Cell Subsets in Clinical Manifestations of Psoriasis","volume":"2016","author":"Diani","year":"2016","journal-title":"Immunol. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.1038\/s41598-019-43899-9","article-title":"Th1, Th17, and Treg Responses are Differently Modulated by TNF-\u03b1 Inhibitors and Methotrexate in Psoriasis Patients","volume":"9","author":"Furiati","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Rendon, A., and Sch\u00e4kel, K. (2019). Psoriasis Pathogenesis and Treatment. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061475"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3121\/cmr.4.4.294","article-title":"Cytokines and Chemokines in Uveitis\u2014Is there a Correlation with Clinical Phenotype?","volume":"4","author":"Ooi","year":"2006","journal-title":"Clin. Med. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clim.2011.01.014","article-title":"Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis","volume":"139","author":"Struyf","year":"2011","journal-title":"Clin. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1365-2133.2011.10494.x","article-title":"Medical comorbidity associated with psoriasis in adults: A population-based study","volume":"165","author":"Yang","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"f5961","DOI":"10.1136\/bmj.f5961","article-title":"Risk of moderate to advanced kidney disease in patients with psoriasis: Population based cohort study","volume":"347","author":"Wan","year":"2013","journal-title":"BMJ"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2340\/00015555-0642","article-title":"Epidemiological Study of Psoriasis in the National Health Insurance Database in Taiwan","volume":"89","author":"Chang","year":"2009","journal-title":"Acta Derm. Venereol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jdermsci.2011.03.002","article-title":"Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan","volume":"63","author":"Tsai","year":"2011","journal-title":"J. Dermatol. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajo.2004.08.053","article-title":"Psoriatic uveitis: A distinct clinical entity?","volume":"139","author":"Durrani","year":"2005","journal-title":"Am. J. Ophthalmol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/4\/627\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T11:48:39Z","timestamp":1771847319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/4\/627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["diagnostics16040627"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16040627","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]}}}